KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Tenet Healthcare (THC) Shares Outstanding (Diluted Average) (2016 - 2025)

Tenet Healthcare's Shares Outstanding (Diluted Average) history spans 15 years, with the latest figure at $90.8 million for Q4 2025.

  • For Q4 2025, Shares Outstanding (Diluted Average) fell 7.2% year-over-year to $90.8 million; the TTM value through Dec 2025 reached $90.8 million, down 7.2%, while the annual FY2025 figure was $90.8 million, 7.2% down from the prior year.
  • Shares Outstanding (Diluted Average) for Q4 2025 was $90.8 million at Tenet Healthcare, down from $91.8 million in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $114.1 million in Q2 2022 and bottomed at $90.8 million in Q4 2025.
  • The 5-year median for Shares Outstanding (Diluted Average) is $105.2 million (2023), against an average of $103.5 million.
  • The largest annual shift saw Shares Outstanding (Diluted Average) increased 5.3% in 2022 before it decreased 7.63% in 2023.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $108.6 million in 2021, then rose by 1.79% to $110.5 million in 2022, then dropped by 5.17% to $104.8 million in 2023, then decreased by 6.6% to $97.9 million in 2024, then decreased by 7.2% to $90.8 million in 2025.
  • Per Business Quant, the three most recent readings for THC's Shares Outstanding (Diluted Average) are $90.8 million (Q4 2025), $91.8 million (Q3 2025), and $93.4 million (Q2 2025).